August 28, 2019 — X-ray therapy systems developer Xstrahl announced the launch of the new SARRP (small animal radiation research platform) beamline pre-clinical radiation research and computed tomography (CT) imaging platform. The system was launched at the 2019 International Congress of Radiation Research (ICRR), Aug. 25-29 in Manchester, U.K.
Extendable with the Xstrahl MuriGlo, which the company calls the industry's first 3-D bioluminescent optical imaging modality, the new SARRP beamline enables researchers using beamline experiments to achieve high-quality images. The system uses onboard high-resolution cone-beam CT imaging and 3-D bioluminescent tomographic imaging to target micro beams (down to 0.5mm) to an accuracy of 200 µm. The SARRP allows the user to image the animal, contour the tumor/target and organs at risk, evaluate the dose and deliver the desired treatment.
For more information: www.xstrahl.com
April 18, 2024 
